Conferences ASCO20 Moves From McCormick Place: Oncologists Prepare for a Virtual Meeting With the ASCO 2020 Annual Meeting just days away, oncologists are nearly universally planning to “attend” this year’s virtual meeting. However, their participation in the meeting will be less in real-time and
Conferences AAN 2020 Abstracts Released - What We're Watching in Multiple Sclerosis As of March 13, the AAN annual meeting has been cancelled due to the ongoing global COVID-19 (Coronavirus) pandemic. We'll be keeping a close eye on any plans to hold events digitally and
Conferences Treating migraine was a major topic at AAPM 2020 - Here’s how migraine treaters perceive the anti-CGRPs While opioid abuse deterrence and deprescribing topics were again center stage at the American Academy of Pain Medicine (AAPM) Annual Meeting this year—held February 26-March 1 in National Harbor, MD—headache and
Conferences ASH 2019: Hem-oncs share their perspective on the latest in MM and CLL treatment among other key topics Nearly 30,000 hematology specialists gathered for this year’s 2019 American Society of Hematology (ASH) annual meeting held Dec 7-10 in Orlando, Florida. This year’s conference delivered on its promise to
Conferences Getting ready for ASH 2019: Perspective from the ZoomRx hem-onc panel The ASH 2019 Annual Meeting kicks-off this Saturday (12/7) in Orlando. Our survey of 51 practicing hematologists-oncologists indicated a great deal of excitement and anticipation, as they prepare for the meeting. In
Conferences Cardiologists share their perspective on The Medicines Co.'s inclisiran and other key events from AHA's 2019 Scientific Sessions Following AHA 2019 Scientific Sessions, Novartis announced its intention to buy The Medicines Company for nearly $10B, based on promising results on its small interfering RNA (siRNA) therapy, inclisiran. The therapy targets PCSK9
Conferences JAKs continue to capture attention, new MOAs stir excitement at ACR 2019 This year’s annual meeting held November 8-13 did not disappoint according to a ZoomRx survey with 35 rheumatologists who attended the conference.
Conferences Oncologists on ESMO 2019 and the Potential Impact of Key PARP Inhibitor Data Following this year’s ESMO annual meeting we asked a group of oncologists practicing in the US to weigh in on Europe’s biggest oncology conference. Oncologists expressed general excitement about the meeting,
Conferences Oncologists reflect on ASCO 2019 The data shared at this year's ASCO Annual Meeting moved the field of clinical oncology forward. Our survey with over 60 oncologists who attended the conference shows that ASCO 2019 did not disappoint.
Research ZoomRx, MGH, and the Sumaira Foundation Collaborate on Newly Published NMO Research When approached by the Global Neurology Research Group at Mass General Hospital (along with the Sumaira Foundation) with the opportunity to collaborate on a global study of neuromyelitis optica (NMO), we were eager
Conferences Practicing Oncologists Weigh In on ASCO's 2019 Annual Meeting With ASCO just days away, oncologists are divided in their outlook for this year's meeting. In our survey of 54 practicing oncologists who plan on attending the conference, half (52%) reported they expect
Conferences Breakthrough Treatments and Pharma's Pricing Dilemma - Perspective from AAN 2019 The recent 2019 AAN conference (May 4-10, Philadelphia) brought promising new data in rare diseases, generating a great deal of excitement and anticipation for new therapies.
